CXCL14 and metabolic dysfunction-associated steatohepatitis: Notably, CXCL14, which is downregulated in NASH-HCC, has been shown to be positively associated with the TIL pathway, suggesting its potential role in promoting immune cell infiltration within the tumor microenvironment of oral cavity squamous cell carcinoma [19].